Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. Client, organization or corporation number: 5088
Share this search Create an alert

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (64)
Results: 1-50 | Export
  1. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 64 of 64 (2024-05-01 to present)
    Posted: 2024-06-06
    Subject matter details: 18
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  2. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 63 of 64 (2024-04-01 to 2024-05-01)
    Posted: 2024-05-03
    Subject matter details: 18
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  3. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 62 of 64 (2024-03-15 to 2024-04-01)
    Posted: 2024-03-15
    Subject matter details: 18
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  4. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 61 of 64 (2024-02-13 to 2024-03-15)
    Posted: 2024-02-16
    Subject matter details: 18
    Government institutions: 17
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  5. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 60 of 64 (2023-12-31 to 2024-02-13)
    Posted: 2024-01-16
    Subject matter details: 18
    Government institutions: 16
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  6. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 59 of 64 (2023-12-12 to 2023-12-31)
    Posted: 2023-12-14
    Subject matter details: 18
    Government institutions: 16
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 10
  7. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 58 of 64 (2023-11-01 to 2023-12-12)
    Posted: 2023-12-07
    Subject matter details: 18
    Government institutions: 15
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  8. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 57 of 64 (2023-08-21 to 2023-11-01)
    Posted: 2023-08-21
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  9. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 56 of 64 (2023-07-11 to 2023-08-21)
    Posted: 2023-07-11
    Subject matter details: 18
    Government institutions: 11
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 12
  10. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 55 of 64 (2023-06-02 to 2023-07-11)
    Posted: 2023-06-02
    Subject matter details: 18
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  11. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 54 of 64 (2023-01-26 to 2023-06-02)
    Posted: 2023-03-31
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  12. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Sridhar Venkatesh, General Manager and President
    Registration: 53 of 64 (2022-12-01 to 2023-01-26)
    Posted: 2022-12-02
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  13. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 51 of 64 (2022-11-23 to 2022-11-23)
    Posted: 2022-11-24
    Subject matter details: 18
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  14. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 52 of 64 (2022-11-23 to 2022-12-01)
    Posted: 2022-11-28
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  15. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 50 of 64 (2022-09-06 to 2022-11-23)
    Posted: 2022-09-06
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  16. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Zach Gana, Interim President and Senior Finance Director
    Registration: 49 of 64 (2022-07-18 to 2022-09-06)
    Posted: 2022-07-26
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  17. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 48 of 64 (2022-02-16 to 2022-07-18)
    Posted: 2022-02-16
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  18. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 47 of 64 (2021-11-04 to 2022-02-16)
    Posted: 2021-11-04
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  19. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 46 of 64 (2021-03-01 to 2021-11-04)
    Posted: 2021-03-01
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 8
  20. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 45 of 64 (2021-02-03 to 2021-03-01)
    Posted: 2021-02-03
    Subject matter details: 16
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  21. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 42 of 64 (2020-09-01 to 2020-09-01)
    Posted: 2020-09-21
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  22. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 43 of 64 (2020-09-01 to 2020-09-01)
    Posted: 2020-09-23
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  23. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Faris El-Refaie, President
    Registration: 44 of 64 (2020-09-01 to 2021-02-03)
    Posted: 2020-10-22
    Subject matter details: 15
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  24. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 41 of 64 (2020-07-02 to 2020-09-01)
    Posted: 2020-07-02
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  25. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 40 of 64 (2020-01-31 to 2020-07-02)
    Posted: 2020-02-05
    Subject matter details: 14
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 7
  26. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 39 of 64 (2019-09-16 to 2020-01-31)
    Posted: 2019-09-17
    Subject matter details: 14
    Government institutions: 21
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  27. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 38 of 64 (2019-07-03 to 2019-09-16)
    Posted: 2019-07-12
    Subject matter details: 14
    Government institutions: 21
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  28. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 37 of 64 (2019-02-12 to 2019-07-03)
    Posted: 2019-02-13
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  29. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 36 of 64 (2019-01-14 to 2019-02-12)
    Posted: 2019-01-16
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  30. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 35 of 64 (2018-08-27 to 2019-01-14)
    Posted: 2018-08-27
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  31. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Yoo-Seok Hong, President
    Registration: 34 of 64 (2018-03-01 to 2018-08-27)
    Posted: 2018-04-17
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  32. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Josee Gravelle, General Counsel
    Registration: 33 of 64 (2018-02-01 to 2018-03-01)
    Posted: 2018-03-16
    Subject matter details: 12
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  33. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 32 of 64 (2017-07-27 to 2018-02-01)
    Posted: 2017-08-09
    Subject matter details: 13
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  34. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 31 of 64 (2017-02-13 to 2017-07-27)
    Posted: 2017-02-16
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  35. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 30 of 64 (2016-03-08 to 2017-02-13)
    Posted: 2016-03-08
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 1
  36. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 29 of 64 (2015-08-18 to 2016-03-08)
    Posted: 2015-08-19
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  37. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 28 of 64 (2015-05-06 to 2015-08-18)
    Posted: 2015-05-07
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  38. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 27 of 64 (2015-01-15 to 2015-05-06)
    Posted: 2015-01-16
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  39. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 26 of 64 (2014-06-10 to 2015-01-15)
    Posted: 2014-06-12
    Subject matter details: 12
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  40. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 25 of 64 (2013-08-14 to 2014-06-02)
    Posted: 2013-08-15
    Subject matter details: 10
    Government institutions: 24
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  41. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lirette, President and Chief Executive Officer
    Registration: 24 of 64 (2012-06-15 to 2013-08-02)
    Posted: 2012-08-09
    Subject matter details: 9
    Government institutions: 25
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 7
  42. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 23 of 64 (2012-05-28 to 2012-06-15)
    Posted: 2012-06-13
    Subject matter details: 9
    Government institutions: 25
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  43. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 22 of 64 (2012-02-17 to 2012-05-28)
    Posted: 2012-02-24
    Subject matter details: 9
    Government institutions: 24
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  44. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 21 of 64 (2011-12-08 to 2012-02-17)
    Posted: 2011-12-08
    Subject matter details: 9
    Government institutions: 24
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  45. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 20 of 64 (2011-10-18 to 2011-12-08)
    Posted: 2011-11-14
    Subject matter details: 9
    Government institutions: 23
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  46. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 19 of 64 (2011-06-20 to 2011-10-18)
    Posted: 2011-06-20
    Subject matter details: 9
    Government institutions: 23
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 8
  47. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 18 of 64 (2011-06-09 to 2011-06-20)
    Posted: 2011-06-13
    Subject matter details: 9
    Government institutions: 23
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 7
  48. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 17 of 64 (2010-04-19 to 2011-06-02)
    Posted: 2010-04-20
    Subject matter details: 8
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  49. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 16 of 64 (2010-02-11 to 2010-04-19)
    Posted: 2010-02-17
    Subject matter details: 8
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7
  50. GlaxoSmithKline
    Type: In-house Corporation
    Responsible officer: Paul Lucas, President and Chief Executive Officer
    Registration: 15 of 64 (2009-12-10 to 2010-02-11)
    Posted: 2009-12-14
    Subject matter details: 8
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 7

Date Modified: